Dong-A Socio Holdings Competitors and Similar CompaniesClear all

Dong-A Socio Holdings's competitors and similar companies include Taejoon, Jubilant Radiopharma, Almac Group and Rational Vaccines.

	Dong-A Socio Holdings Dong-A Socio Holdings (동아쏘시오홀딩스, also known as Dong-A ST) is a company that manufactures and sells pharmaceuticals.	Taejoon Taejoon is a pharmaceutical company.	Jubilant Radiopharma Jubilant Radiopharma (also known as Jubilant DraxImage) is a company that provides pharmaceutical solutions.	Almac Group Almac Group is a company that provides a range of services across the drug development lifecycle.	Rational Vaccines Rational Vaccines is a company developing a vaccine for herpes.
Founding Date	Founding Date 1932	Founding Date 1978	Founding Date 1955	Founding Date 2002	Founding Date 2015
Type	Type Public	Type Private	Type Subsidiary	Type Subsidiary	Type Private
Tags	Tags Healthcare drug development medical diagnostics pharma	Tags Healthcare drug development medical diagnostics pharma	Tags Healthcare drug development medical diagnostics pharma	Tags Healthcare chemicals clinical research drug development pharma	Tags Healthcare drug development medical diagnostics pharma
Locations	Locations Seoul, KR HQ Sao Paulo, BR Cerritos, US	Locations HQ	Locations Kirkland, CA HQ Noida, IN	Locations Craigavon, GB HQ Athlone, IE Dundalk, IE Minato City, JP Singapore, SG Alderley Edge, GB Belfast, GB see more	Locations Cambridge, US HQ Woburn, US
Employees	Employees 922% increase	Employees 52	Employees 1381% increase	Employees 4,7021% increase	Employees 12
Financial
Revenue (est.)	Revenue (est.) ₩1.4t (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) £735.1m (FY, 2021)	Revenue (est.) N/A
Cost of goods	Cost of goods ₩894.9b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods £474.7m (FY, 2021)	Cost of goods N/A
Gross profit	Gross profit ₩542.4b (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit £260.3m (FY, 2021)	Gross profit N/A
Net income	Net income ₩91.5b (FY, 2025)	Net income N/A	Net income N/A	Net income £64.2m (FY, 2021)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 1m	Total funding raised $ 8.9m